LncRNA938/ TAF9/TTK axis promotes EMT and serves as a therapeutic target in hepatoblastoma
The lncRNA938-TAF9-TTK axis is a critical driver of HB progression. Targeting this axis, particularly through TTK inhibition, represents a novel therapeutic strategy against HB.
Authors
- Chengzhan Zhu (ORCID: https://orcid.org/0000-0002-2775-5863)
- Yuwei Xie (ORCID: https://orcid.org/0000-0001-5652-6413)
- Jin Chen (ORCID: https://orcid.org/0000-0003-4757-512X)
- Bingzi Dong (ORCID: https://orcid.org/0000-0003-2446-0725)
- Qian Dong (ORCID: https://orcid.org/0000-0002-1289-529X)
- Xin Chen
- Shengze Wu
- Fangqian Du
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1186/s12967-025-06809-4
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Foundation of Shandong Province